Dupilumab reduces systemic corticosteroid use in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbation history
Ducharme FM, Sher LD, Hamelmann E, de Mir I, Xia C, Gall R, Jacob-Nara JA, Sacks H, Rowe PJ, Ledanois O, Deniz Y (2023)
Value in Health 26(12, Suppl.): S477.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Ducharme, F. M.;
Sher, L. D.;
Hamelmann, EckardUniBi;
de Mir, I;
Xia, C.;
Gall, R.;
Jacob-Nara, J. A.;
Sacks, H.;
Rowe, P. J.;
Ledanois, O.;
Deniz, Y.
Erscheinungsjahr
2023
Serien- oder Zeitschriftentitel
Value in Health
Band
26
Ausgabe
12, Suppl.
Seite(n)
S477
Konferenz
ISPOR Europe 2023
Konferenzort
Copenhagen, Denmark
Konferenzdatum
2023-11-11 – 2023-11-15
ISSN
1098-3015
eISSN
1524-4733
Page URI
https://pub.uni-bielefeld.de/record/2987537
Zitieren
Ducharme FM, Sher LD, Hamelmann E, et al. Dupilumab reduces systemic corticosteroid use in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbation history. Value in Health. 2023;26(12, Suppl.):S477.
Ducharme, F. M., Sher, L. D., Hamelmann, E., de Mir, I., Xia, C., Gall, R., Jacob-Nara, J. A., et al. (2023). Dupilumab reduces systemic corticosteroid use in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbation history. Value in Health, 26(12, Suppl.), S477. https://doi.org/10.1016/j.jval.2023.09.2583
Ducharme, F. M., Sher, L. D., Hamelmann, Eckard, de Mir, I, Xia, C., Gall, R., Jacob-Nara, J. A., et al. 2023. “Dupilumab reduces systemic corticosteroid use in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbation history”, Value in Health, 26 (12, Suppl.): S477.
Ducharme, F. M., Sher, L. D., Hamelmann, E., de Mir, I., Xia, C., Gall, R., Jacob-Nara, J. A., Sacks, H., Rowe, P. J., Ledanois, O., et al. (2023). Dupilumab reduces systemic corticosteroid use in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbation history. Value in Health 26, S477.
Ducharme, F.M., et al., 2023. Dupilumab reduces systemic corticosteroid use in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbation history. Value in Health, 26(12, Suppl.), p S477.
F.M. Ducharme, et al., “Dupilumab reduces systemic corticosteroid use in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbation history”, Value in Health, vol. 26, 2023, pp. S477.
Ducharme, F.M., Sher, L.D., Hamelmann, E., de Mir, I., Xia, C., Gall, R., Jacob-Nara, J.A., Sacks, H., Rowe, P.J., Ledanois, O., Deniz, Y.: Dupilumab reduces systemic corticosteroid use in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbation history. Value in Health. 26, S477 (2023).
Ducharme, F. M., Sher, L. D., Hamelmann, Eckard, de Mir, I, Xia, C., Gall, R., Jacob-Nara, J. A., Sacks, H., Rowe, P. J., Ledanois, O., and Deniz, Y. “Dupilumab reduces systemic corticosteroid use in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbation history”. Value in Health 26.12, Suppl. (2023): S477.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar